Hsc70 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{"content": "# Hsc70 Protein (HSPA8)\n\n<div class="infobox infobox-protein">\n \n <th colspan="2" style="background:#4a90d9; color:white;">Hsc70 (Heat Shock Protein 70 Cognate)\n \n \n \n \n \n
| Gene | <a href="/genes/hspa8">HSPA8 |
| UniProt ID | <a href="https://www.uniprot.org/uniprot/P11142">P11142 |
| Molecular Weight | 71 kDa |
| Subcellular Localization | Cytoplasm, nucleus, organelles |
| Protein Family | Hsp70 family |
Hsc70 (Heat Shock Cognate 70 kDa Protein / HSPA8) is a constitutively expressed molecular chaperone that plays essential roles in protein folding, refolding, and degradation within neuronal cells. As a member of the Hsp70 family, Hsc70 is crucial for maintaining cellular proteostasis and is particularly important in the context of neurodegenerative diseases, where protein aggregation is a hallmark feature.
Hsc70 (Heat Shock Cognate 70 kDa protein), also known as HSPA8, is a constitutively expressed molecular chaperone that plays essential roles in protein folding, refolding, and degradation. Unlike inducible Hsp70 (HSPA1A), Hsc70 is expressed at high levels under normal conditions and is upregulated during stress.
Hsc70 participates in multiple cellular processes, including: (1) co-translational protein folding, (2) refolding of stress-denatured proteins, (3) targeting misfolded proteins for degradation via the proteasome or autophagy, (4) disassembly of protein complexes, and (5) assisting translocation of proteins across membranes.
In the nervous system, Hsc70 is particularly important for synaptic function, where it helps maintain the pool of properly folded synaptic proteins and facilitates synaptic vesicle recycling.
Alzheimer's Disease: Hsc70 is involved in clearing amyloid-beta aggregates and tau phosphorylated species. The protein can target these pathological proteins for autophagic degradation. Hsc70 levels are altered in AD brains, and the protein colocalizes with amyloid plaques and neurofibrillary tangles.
Parkinson's Disease: Hsc70 plays a critical role in clearing alpha-synuclein aggregates through chaperone-mediated autophagy (CMA). Mutations affecting Hsc70 function or expression may contribute to PD pathogenesis. The protein is also involved in mitochondrial quality control.
Huntington's Disease: Hsc70 helps clear mutant huntingtin aggregates and may have neuroprotective effects. The protein interacts with the autophagy machinery to target misfolded proteins for degradation.
ALS: Hsc70 is involved in clearing TDP-43 and FUS aggregates, which are characteristic of ALS pathology. The protein may have therapeutic potential for enhancing aggregate clearance.
Hsc70 activators are being explored as potential therapies for neurodegenerative diseases. Small molecules that enhance Hsc70 activity could boost clearance of toxic protein aggregates. Conversely, Hsc70 inhibitors may have applications in certain contexts where reducing chaperone activity could promote apoptosis in diseased cells.
Research is focused on developing brain-penetrant Hsc70 modulators and understanding the specific pathways through which Hsc70 clears disease-related proteins. Gene therapy approaches to increase Hsc70 expression are also being explored.
Hsc70 (Heat Shock Cognate 70 kDa protein), also known as HSPA8, is a constitutively expressed molecular chaperone that plays essential roles in protein folding, refolding, and degradation. Unlike inducible Hsp70 (HSPA1A), Hsc70 is expressed at high levels under normal conditions and is upregulated during stress.
Hsc70 participates in multiple cellular processes, including: (1) co-translational protein folding, (2) refolding of stress-denatured proteins, (3) targeting misfolded proteins for degradation via the proteasome or autophagy, (4) disassembly of protein complexes, and (5) assisting translocation of proteins across membranes.
In the nervous system, Hsc70 is particularly important for synaptic function, where it helps maintain the pool of properly folded synaptic proteins and facilitates synaptic vesicle recycling.
Alzheimer's Disease: Hsc70 is involved in clearing amyloid-beta aggregates and tau phosphorylated species. The protein can target these pathological proteins for autophagic degradation. Hsc70 levels are altered in AD brains, and the protein colocalizes with amyloid plaques and neurofibrillary tangles.
Parkinson's Disease: Hsc70 plays a critical role in clearing alpha-synuclein aggregates through chaperone-mediated autophagy (CMA). Mutations affecting Hsc70 function or expression may contribute to PD pathogenesis. The protein is also involved in mitochondrial quality control.
Huntington's Disease: Hsc70 helps clear mutant huntingtin aggregates and may have neuroprotective effects. The protein interacts with the autophagy machinery to target misfolded proteins for degradation.
ALS: Hsc70 is involved in clearing TDP-43 and FUS aggregates, which are characteristic of ALS pathology. The protein may have therapeutic potential for enhancing aggregate clearance.
Hsc70 activators are being explored as potential therapies for neurodegenerative diseases. Small molecules that enhance Hsc70 activity could boost clearance of toxic protein aggregates. Conversely, Hsc70 inhibitors may have applications in certain contexts where reducing chaperone activity could promote apoptosis in diseased cells.
Research is focused on developing brain-penetrant Hsc70 modulators and understanding the specific pathways through which Hsc70 clears disease-related proteins. Gene therapy approaches to increase Hsc70 expression are also being explored.
The study of Hsc70 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hartl FU, Hayer-Hartl M. Molecular chaperones in protein folding. Science. 2009;323(5914):821-823. DOI:10.1126/science.1170852 ↩︎ ↩︎
Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005;62(6):670-684. ↩︎
Zhang Y, et al. Hsc70 maintains neuronal proteostasis and synaptic function. Nat Neurosci. 2020;23(10):1225-1235. ↩︎
Balchin D, et al. In vivo aspects of Hsp70 function. J Biol Chem. 2018;293(25):9928-9938. ↩︎
Chen L, et al. Hsp70 and autophagy in neurodegenerative diseases. Free Radic Biol Med. 2021;165:282-295. ↩︎